CMTA - Clementia Pharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development42,398.07725,724.19316,352.19714,011.828
Selling General and Administrative16,958.5939,731.4633,766.185,698.444
Non Recurring----
Others----
Total Operating Expenses-35,455.65620,118.37719,710.272
Operating Income or Loss--35,455.656-20,118.377-19,710.272
Income from Continuing Operations
Total Other Income/Expenses Net2,196.189-79,355.772-37,247.148-56,030.451
Earnings Before Interest and Taxes--35,455.656-20,118.377-19,710.272
Interest Expense--2,479.162-3,742.178-2,378.992
Income Before Tax--114,811.428-57,365.525-75,740.723
Income Tax Expense-643.765146.454156.22
Minority Interest----
Net Income From Continuing Ops--115,455.193-57,511.979-75,896.943
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income--115,455.193-57,511.979-75,896.943
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares--115,455.193-57,511.979-75,896.943